Jansen, Mylène P. http://orcid.org/0000-0003-1929-6350
Roemer, Frank W.
Marijnissen, Anne Karien C. A.
Kloppenburg, Margreet
Blanco, Francisco J.
Haugen, Ida K.
Berenbaum, Francis
Lafeber, Floris P. J. G.
Welsing, Paco M. J.
Mastbergen, Simon C.
Wirth, Wolfgang
Funding for this research was provided by:
Innovative Medicines Initiative (115770)
Article History
Received: 19 September 2022
Revised: 2 December 2022
Accepted: 9 December 2022
First Online: 6 January 2023
Declarations
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: FWR: shareholder of Boston Imaging Core Lab (BICL), LLC and consultant to Calibr and Grünenthal.
: MK: consulting fees from Abbvie, Pfizer, Kiniksa, Flexion, Galapagos, Jansen, CHDR, Novartis, UCB, all paid to institution.
: FJB: funding from Gedeon Richter Plc., Bristol-Myers Squibb International Corporation (BMSIC), Sun Pharma Global FZE, Celgene Corporation, Janssen Cilag International N.V, Janssen Research & Development, Viela Bio, Inc., Astrazeneca AB, UCB BIOSCIENCES GMBH, UCB BIOPHARMA SPRL, AbbVie Deutschland GmbH & Co.KG, Merck KGaA, Amgen, Inc., Novartis Farmacéutica, S.A., Boehringer Ingelheim España, S.A, CSL Behring, LLC, Glaxosmithkline Research & Development Limited, Pfizer Inc, Lilly S.A., Corbus Pharmaceuticals Inc., Biohope Scientific Solutions for Human Health S.L., Centrexion Therapeutics Corp., Sanofi, MEIJI FARMA S.A., Kiniksa Pharmaceuticals, Ltd. Grunenthal, Asofarma Mexico, Gebro Pharma, Roche, Galapagos, Regeneron.
: IKH: research grant (ADVANCE) from Pfizer (payment to institution) and consulting fees from Novartis and GSK, outside of the submitted work.
: FB: Institutional grants from TRB Chemedica and Pfizer. Consulting fees from AstraZeneca, Boehringer Ingelheim, Bone Therapeutics, Cellprothera, Galapagos, Gilead, Grunenthal, GSK, Eli Lilly, MerckSerono, Nordic Bioscience, Novartis, Pfizer, Sanofi, Servier, Peptinov, 4P Pharma. Honoraria for lectures from Pfizer, Eli Lilly, Viatris, Aché Laboratories. SShareholder of 4Moving Biotech, 4P Pharma and Peptinov.
: WW: Employee and shareholder of Chondrometrics GmbH and consulting fees from Galapagos NV.
: The other authors have nothing to disclose.